Subsequent Events	12 Months Ended
Dec. 31, 2015
Notes to Financial Statements
8. Subsequent Events	The Company has evaluated all events that occur after the balance sheet date through the date when the financial statements were issued to determine if they must be reported. The Management of the Company determined that there were no reportable subsequent event(s) to be disclosed. Effective January 2, 2016, the Company and Embles Financial agreed to the conversion of the $10,000 payable to Embles Financial into a convertible promissory note. See Note 5. The note bears interest at the rate of 12% per annum, which accrues monthly. The note matures on January 2, 2017. The note has a conversion feature of $0.04 per share, which was based on the Enterprise value of the Company. A beneficial conversion feature was not applicable as the Company has yet to publicly trade its common stock and no value was available.

Subsequent Events

12 Months Ended

Dec. 31, 2015

The Company has evaluated all events that occur after the balance sheet date through the date when the financial statements were issued to determine if they must be reported. The Management of the Company determined that there were no reportable subsequent event(s) to be disclosed.

Effective January 2, 2016, the Company and Embles Financial agreed to the conversion of the $10,000 payable to Embles Financial into a convertible promissory note. See Note 5. The note bears interest at the rate of 12% per annum, which accrues monthly. The note matures on January 2, 2017. The note has a conversion feature of $0.04 per share, which was based on the Enterprise value of the Company. A beneficial conversion feature was not applicable as the Company has yet to publicly trade its common stock and no value was available.

MEDRESPONSE CORP. 10-K